WeightWatchers

The FreeStyle Libre 2, part of the integrated offering with WeightWatchers. (Image courtesy of Abbott)

Abbott (NYSE: ABT) + and WeightWatchers today announced the availability of a connected app for people living with diabetes.

In August 2022, the companies announced a collaboration to integrate continuous glucose monitoring (CGM) with the WW diabetes-tailored plan. The integrated offering provides a mobile experience with information and insights needed for those with diabetes. It helps to make healthy adjustments to their diet, improve their glucose levels and gain more control of their health.

The app helps people with diabetes understand how food and activity impact their glucose levels. WeightWatchers members who follow the tailored plan can now access their glucose data from the Abbott FreeStyle Libre 2 CGM. This all works within their WW app while under guidance from the WW diabetes-tailored plan.

Read more

Abbott (NYSE:ABT) announced that it entered into a strategic partnership with WeightWatchers to help people living with diabetes.

The companies will work together to integrate WeightWatchers’ diabetes-tailored weight management program with Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) products to help them better understand and manage their diabetes and weight.

Get the full story at our sister site, Drug Delivery Business News.